Shares of Hims & Hers Health (NYSE: HIMS) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as ...
The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results